Table 1.

Demographic and clinical characteristics of the 117 patients included in the study

	n (%)
Gender
Male	79 (67.5)
Female	38 (32.5)
Age (years)†	41.1 (9.4)
HCV	50 (42.7)
Years since HIV diagnosis†	10.5 (5.2)
Months on ARV therapy‡	20.0 (8.5–39.0)
Current ARV treatment
NNRTI	60 (51.3)
PI	57 (48.7)
Missing doses within the previous week
0	96 (82.1)
1	16 (13.7)
≥2	5 (4.2)

Data are expressed as n (%), except where noted. IVDU intravenous drugs user; HCV hepatitis C virus; ARV antiretroviral; NRTI nucleoside reverse transcriptase inhibitor; NNRTI non-nucleoside reverse transcriptase inhibitor; PI protease inhibitor

^†mean (SD)

^‡Median (interquartile range).